(Q40953047)

25 September 2017

1 reference

title

Potential role of thiazolidinediones in older diabetic patients (English)

1 reference

25 September 2017

F Umeda

1

1 reference

25 September 2017

publication date

1 November 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

7

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

331-337

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199507050-00001

25 September 2017

exact match

0 references

cites work

Diabetes in the elderly: the Oxford Community Diabetes Study

1 reference

12 December 2020

Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform.

1 reference

12 December 2020

Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture

1 reference

12 December 2020

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

1 reference

12 December 2020

A new potentiator of insulin action. Post-receptor activation in vitro

1 reference

12 December 2020

Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.

1 reference

12 December 2020

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

1 reference

12 December 2020

Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

1 reference

12 December 2020

Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.

1 reference

12 December 2020

Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

12 December 2020

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts

1 reference

12 December 2020

Insulin sensitivity and secretion in healthy elderly human subjects with 'abnormal' glucose tolerance

1 reference

12 December 2020

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

1 reference

12 December 2020

10.2165/00002512-199507050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

25 September 2017

1035214203

0 references

1 reference